Menthol 4%
Over-the-CounterNombres comerciales: DCH Cooling Pain Relief
About This Medication
Topical product applied to the skin for localized treatment and symptom relief.
Principios Activos
| Ingrediente | Concentración |
|---|---|
| Menthol | - |
Indicaciones y Uso
Dosificación y Administración
Advertencias y Precauciones
For external use only. When using this product keep out of eyes. In case of contact with eyes, flush thoroughly with water. Avoid contact with broken skin, do not bandage tightly, and do not use with heating pad. Stop use and ask a doctor if condition worsens, symptoms last more than 7 days or clear and occur again within a few days.
Frequently Asked Questions
For the temporary relief of minor aches and pains associated with arthritis, simple backache, strains, sprains, and bruises.
• adults and children 12 years and older, apply to affected area not more than 3 to 4 times daily. • Children under 12 years old, ask a doctor
For external use only. When using this product keep out of eyes. In case of contact with eyes, flush thoroughly with water. Avoid contact with broken skin, do not bandage tightly, and do not use with heating pad. Stop use and ask a doctor if condition worsens, symptoms last more than 7 days or clear and occur again within a few days.
Menthol 4% is available over the counter (OTC) without a prescription.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Menthol 4% drug label (National Library of Medicine)
- • openFDA — Menthol 4% label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 415974 (NLM Normalized Drug Names)
- • NDC Directory — Menthol 4% (FDA National Drug Code)
Aviso Médico
La información en esta página tiene fines exclusivamente educativos y no debe utilizarse como sustituto del consejo médico profesional, diagnóstico o tratamiento.
Siempre consulte a su médico u otro proveedor de salud calificado ante cualquier pregunta que pueda tener sobre una condición médica o medicamento.
Fuentes de datos: DailyMed (NLM), openFDA, MFDS